Evaluation of CD30 expression in B ALL and its correlation with MRD(Minimum Residual Disease)

Background: This study was conducted to evaluate CD30 expression in minimum residual disease after chemotherapy in B-acute lymphoblastic leukemia (B-ALL). Materials and Methods: This was a cross-sectional study on 30 new cases of B-ALL between 2018 and 2019. We checked CD30 expressions in fresh bone...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amirhossein Kazemian, Pardis Nematollahi
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
R
Acceso en línea:https://doaj.org/article/01630613ecdf4e838d251897df95beff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!